Eligo Bioscience, a gene-editing company focused on addressing diseases driven by the expression of bacterial genes from the microbiome, has published a study in Nature that unlocks genome editing of bacteria in the gut.
Eligo Bioscience, a gene-editing company focused on addressing diseases driven by the expression of bacterial genes from the microbiome, has published a study in Nature that unlocks genome editing of bacteria in the gut.
© 2024 FreshHive.ca - Lifestyle News. Served Fresh.